Phlox Therapeutics
Curing genetic heart diseases
- Business Model
- B2B
- Website
- phloxtherapeutics.com
- Last Round
- Venture RoundNov 2024
- Rounds
- 2
About
RNA-based biotech therapeutic company
Summary
Phlox Therapeutics is a Biotech company. Its most recent funding was a Venture Round in Nov 2024.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2024
Sign up to see all 2 events
Funding: Extension Round through Venture Round. Amounts, valuations, and investors where available.
Similar Companies
Specialty pharmaceutical company focused on addressing therapeutic needs in the fields of psychia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/phlox-therapeutics"><img src="https://indexed.vc/api/badge/company/phlox-therapeutics" alt="Phlox Therapeutics on Indexed.vc" width="260" height="76" /></a>